Potential neurological value of statins increases.
Bonetta
Laura
L
D000544:Alzheimer Disease / Q000517:prevention & control*; D000924:Anticholesteremic Agents / Q000191:economics / Q000627:therapeutic use*; D000069059:Atorvastatin; D003365:Costs and Cost Analysis; D006538:Heptanoic Acids / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics / Q000627:therapeutic use*; D008077:Lipoproteins, LDL / Q000097:blood / Q000187:drug effects; D009422:Nervous System Diseases / Q000188:drug therapy*; D011758:Pyrroles / Q000191:economics / Q000627:therapeutic use*; D014481:United States
D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008077:Lipoproteins, LDL; D011758:Pyrroles; D000069059:Atorvastatin